NOVOTECH HEALTH
LIVE

Serial Number

79311087

Owner

Novotech (Australia) Pty Ltd

Attorney

Matthew P. Hintz, Esq.

Filing Date

Oct 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NOVOTECH HEALTH Trademark

Serial Number: 79311087 • Registration: 6641668

NOVOTECH HEALTH is a trademark filed by Novotech (Australia) Pty Ltd on October 26, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Novotech (Australia) Pty Ltd (8 trademarks)

L 3 235 Pyrmont St

Entity Type: 99

Trademark Details

Filing Date

October 26, 2020

Registration Date

February 15, 2022

Published for Opposition

November 30, 2021

Goods & Services

conducting clinical trials for others; conducting and managing clinical trials for others in the field of pharmaceuticals, biotechnology and other related industries; conducting clinical trials for others [scientific research]; providing medical and scientific research information about the results of clinical trials in the nature of clinical trials for pharmaceuticals and biotechnology; scientific research; medical research; preparation of statistics, namely, scientific analysis in the field of clinical trial results for scientific research; preparation of biostatistics, namely, scientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely, medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits, namely, quality evaluation of site compliance with clinical trial protocols and standards; preparation of reports and applications to regulators relating to aspects of clinical trials, namely, providing medical and scientific information and data in the field of conducting clinical trials; provision of medical and scientific research information and data between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards, namely, preparation of reports and applications on the quality and standard of clinical trials; technical writing of clinical report forms which are required by clinical trial drug protocols

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 16, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 22, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 22, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 15, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 15, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Dec 6, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 30, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 28, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 28, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 28, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 28, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2021 TROA
REFUSAL PROCESSED BY IB
Jun 28, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 10, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 10, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 9, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 8, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
May 25, 2021 MAFR
ASSIGNED TO EXAMINER
May 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 21, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 20, 2021 REPR